Dr. Shoaib Sultan Lateef, MD

Dr. Lateef practices at Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health.

Dr. Lateef's NPI, 1740282946, was assigned on June 1, 2005. Dr. Lateef holds North Carolina license 200200941.

Dr. Lateef's primary practice is Atrium Health Carolinas Medical Center, at 1000 Blythe Blvd, Charlotte, NC 28203 in Mecklenburg County. The practice phone is (704) 355-2000.

Dr. Lateef's primary practice is Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health. Dr. Lateef is also affiliated with Atrium Health University City. The medical group on file is Atrium Health Cleveland Imaging. Dmand AI also links Dr. Lateef to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lateef practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Lateef's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Lateef is licensed in North Carolina.

CMS data shows 555 Medicare services from Dr. Lateef across 3 procedure codes in 2024, for 126 Medicare patients. Medicare paid $45,960 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 126 Medicare patients who saw Dr. Lateef in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 29% are also on Medicaid. Their average risk score is 3.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lateef's median patient age at 73, with 55% women.

In 2024, Dr. Lateef wrote 173 Medicare Part D claims for 65 patients. 87% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $6,733 in total drug cost. In 2021, CMS named 68 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Lateef for performance year 2024, reported through an alternative payment model (APM). Dr. Lateef accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lateef as offering telehealth.

CMS Open Payments shows 23 general payments to Dr. Lateef from 10 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $299.